WELL Health Announces Normal Course Issuer Bid
News provided by
Share this article
WELL Health Technologies Corp. (TSXV: WELL) (the
Company or
WELL ), a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector, today announced that it has filed its Notice of an Intention to Make a Normal Course Issuer Bid (
NCIB ) with the Toronto Stock Exchange (
TSX ). The NCIB remains subject to approval by the TSX.
WELL believes that share purchases pursuant to the NCIB will contribute to the facilitation of an orderly market and be in the best interests of the Company and its shareholders. In the event that WELL believes that its common shares begin trading in a price range that does not adequately reflect their underlying value based on WELL s business prospects and strong financial position, WELL may purchase shares pursuant to the NCIB. Depending upon future price movements and other factors, WELL believes that its
Monday s analyst upgrades and downgrades - The Globe and Mail
theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
Friday s analyst upgrades and downgrades - The Globe and Mail
theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
WELL Health Completes Acquisition of CRH Medical
News provided by
Share this article
Monumental acquisition significantly boosts WELL s revenue and EBITDA
(1) profile, dramatically enhances its U.S. operations, and provides WELL with additional inorganic and organic growth opportunities.
WELL s technology and shared services teams will work with CRH to help digitize and modernize operations in a manner similar to how WELL has executed in the primary healthcare space in Canada.
CRH recently reported its audited Q4 2020 results with US$36.8M in quarterly revenue reflecting 21% YoY growth. CRH s adjusted operating EBITDA
(2) for the same period was $16.1M, demonstrating strong 44% adjusted operating EBITDA margin
CRH Medical Securityholders Approve Acquisition by WELL Health
News provided by
Share this article
CRH or the
Company ) today announced that its securityholders approved the acquisition of CRH by a subsidiary of WELL Health Technologies Corp. (
WELL Health ) at the special meeting of CRH securityholders today.
The special resolution approving the arrangement was approved by: (i) 97.30% of the votes cast by CRH shareholders present in person or represented by proxy at the meeting; (ii) 97.49% of the votes cast by CRH shareholders, share unitholders and optionholders voting as a single class present in person or represented by proxy at the meeting; and (iii) 97.27% of the votes cast by minority CRH shareholders in accordance with Part 8 of Multilateral Instrument 61-101 –